دورية أكاديمية
أعرض في EDS

Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface.

التفاصيل البيبلوغرافية
العنوان: Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface.
المؤلفون: de Souza G; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Teixeira SC; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Fajardo Martínez AF; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Silva RJ; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Luz LC; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., de Lima Júnior JP; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Rosini AM; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Dos Santos NCL; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., de Oliveira RM; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Paschoalino M; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Barbosa MC; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Alves RN; Department of Agricultural and Natural Science, Universidade do Estado de Minas Gerais, Ituiutaba, MG, Brazil., Gomes AO; Institute of Natural and Biological Sciences, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil., da Silva CV; Laboratory of Trypanosomatids, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, Brazil., Ferro EAV; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Barbosa BF; Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
المصدر: Frontiers in immunology [Front Immunol] 2023 Oct 16; Vol. 14, pp. 1243480. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مواضيع طبية MeSH: Trypanosoma cruzi* , Toxoplasmosis*/pathology , Chagas Disease*/pathology, Infant, Newborn ; Humans ; Female ; Pregnancy ; Placenta/pathology ; Interleukin-8 ; Recombinant Proteins
مستخلص: Introduction: Toxoplasma gondii is the etiologic agent of toxoplasmosis, a disease that affects about one-third of the human population. Most infected individuals are asymptomatic, but severe cases can occur such as in congenital transmission, which can be aggravated in individuals infected with other pathogens, such as HIV-positive pregnant women. However, it is unknown whether infection by other pathogens, such as Trypanosoma cruzi , the etiologic agent of Chagas disease, as well as one of its proteins, P21, could aggravate T. gondii infection.
Methods: In this sense, we aimed to investigate the impact of T. cruzi and recombinant P21 (rP21) on T. gondii infection in BeWo cells and human placental explants.
Results: Our results showed that T. cruzi infection, as well as rP21, increases invasion and decreases intracellular proliferation of T. gondii in BeWo cells. The increase in invasion promoted by rP21 is dependent on its binding to CXCR4 and the actin cytoskeleton polymerization, while the decrease in proliferation is due to an arrest in the S/M phase in the parasite cell cycle, as well as interleukin (IL)-6 upregulation and IL-8 downmodulation. On the other hand, in human placental villi, rP21 can either increase or decrease T. gondii proliferation, whereas T. cruzi infection increases T. gondii proliferation. This increase can be explained by the induction of an anti-inflammatory environment through an increase in IL-4 and a decrease in IL-6, IL-8, macrophage migration inhibitory factor (MIF), and tumor necrosis factor (TNF)-α production.
Discussion: In conclusion, in situations of coinfection, the presence of T. cruzi may favor the congenital transmission of T. gondii , highlighting the importance of neonatal screening for both diseases, as well as the importance of studies with P21 as a future therapeutic target for the treatment of Chagas disease, since it can also favor T. gondii infection.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 de Souza, Teixeira, Fajardo Martínez, Silva, Luz, Lima Júnior, Rosini, dos Santos, de Oliveira, Paschoalino, Barbosa, Alves, Gomes, da Silva, Ferro and Barbosa.)
References: Front Microbiol. 2018 May 08;9:906. (PMID: 29867817)
Immunobiology. 2023 May;228(3):152357. (PMID: 36857907)
J Immunol Methods. 1983 Dec 16;65(1-2):55-63. (PMID: 6606682)
J Transl Med. 2014 May 19;12:132. (PMID: 24885122)
Nitric Oxide. 2017 Jun 1;66:43-52. (PMID: 28268114)
J Comp Pathol. 2020 Aug;179:52-58. (PMID: 32958148)
Front Cell Dev Biol. 2020 Oct 19;8:569729. (PMID: 33195200)
Lancet. 2018 Jan 6;391(10115):82-94. (PMID: 28673423)
Int J Parasitol. 2000 Nov;30(12-13):1217-58. (PMID: 11113252)
Microbes Infect. 2023 Jul-Aug;25(6):105123. (PMID: 36870599)
BMJ Glob Health. 2018 Oct 11;3(5):e001069. (PMID: 30364393)
Sci Rep. 2015 Nov 17;5:16877. (PMID: 26574156)
Biochem Biophys Res Commun. 2009 Jan 16;378(3):656-61. (PMID: 19061866)
J Trop Med. 2012;2012:758357. (PMID: 22007243)
Parasitol Res. 2021 Sep;120(9):3065-3076. (PMID: 34390383)
Front Immunol. 2020 Oct 07;11:575197. (PMID: 33133091)
Placenta. 2010 Aug;31(8):705-11. (PMID: 20541804)
Braz J Infect Dis. 2014 Nov-Dec;18(6):609-17. (PMID: 25017666)
Front Cell Infect Microbiol. 2017 Jul 26;7:340. (PMID: 28798905)
Blood Transfus. 2015 Oct;13(4):540-50. (PMID: 26513769)
Exp Parasitol. 2016 Sep;168:9-15. (PMID: 27328973)
Front Immunol. 2020 Jun 05;11:1010. (PMID: 32655546)
Clin Microbiol Rev. 2011 Jul;24(3):592-630. (PMID: 21734249)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
J Biomed Sci. 2019 Jan 21;26(1):10. (PMID: 30665403)
Front Microbiol. 2022 Nov 25;13:1020029. (PMID: 36504775)
Front Cell Infect Microbiol. 2020 Jun 30;10:294. (PMID: 32714877)
Sci Rep. 2017 Mar 21;7:44978. (PMID: 28322302)
Pathogens. 2022 Mar 16;11(3):. (PMID: 35335686)
N Engl J Med. 2015 Jul 30;373(5):456-66. (PMID: 26222561)
Mem Inst Oswaldo Cruz. 2022 Jun 27;117:e210304. (PMID: 35766782)
Front Cell Infect Microbiol. 2019 Apr 16;9:103. (PMID: 31041194)
Front Cell Infect Microbiol. 2023 Feb 13;13:1113896. (PMID: 36860986)
Trop Med Infect Dis. 2022 Dec 21;8(1):. (PMID: 36668910)
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221078436. (PMID: 35227108)
Placenta. 2013 Mar;34(3):240-7. (PMID: 23294571)
Placenta. 2014 Mar;35(3):152-62. (PMID: 24433846)
Bull World Health Organ. 2013 Jul 1;91(7):501-8. (PMID: 23825877)
Food Waterborne Parasitol. 2019 Apr 18;15:e00054. (PMID: 32095624)
Parasitology. 2021 May;148(6):703-711. (PMID: 33536085)
Int Immunol. 2018 Mar 10;30(3):113-119. (PMID: 29408976)
PLoS One. 2012;7(4):e35834. (PMID: 22558235)
Front Pediatr. 2022 Jul 06;10:894573. (PMID: 35874584)
Sci Rep. 2021 Jun 16;11(1):12709. (PMID: 34135407)
Malar J. 2007 Jul 09;6:90. (PMID: 17620126)
Cytokine Growth Factor Rev. 2021 Dec;62:15-22. (PMID: 34696979)
Acta Trop. 2002 Feb;81(2):111-22. (PMID: 11801218)
Obstet Gynecol Clin North Am. 2020 Mar;47(1):49-63. (PMID: 32008671)
N Engl J Med. 2014 Jun 5;370(23):2211-8. (PMID: 24897084)
Braz J Infect Dis. 2010 Mar-Apr;14(2):186-9. (PMID: 20563448)
Retrovirology. 2008 Jul 01;5:53. (PMID: 18593480)
J Med Case Rep. 2023 Apr 4;17(1):121. (PMID: 37013596)
Acta Trop. 2018 Oct;186:35-40. (PMID: 30018029)
Acta Parasitol. 2022 Jun;67(2):1015-1023. (PMID: 35013940)
Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:44-50. (PMID: 33075679)
Sci Rep. 2020 Sep 16;10(1):15158. (PMID: 32938966)
Obstet Gynecol Clin North Am. 2020 Mar;47(1):133-146. (PMID: 32008664)
Front Cell Infect Microbiol. 2022 Feb 18;12:799668. (PMID: 35252026)
Acta Trop. 2019 Nov;199:105153. (PMID: 31469971)
Front Microbiol. 2019 Aug 14;10:1854. (PMID: 31474955)
J Vet Med Sci. 2018 Nov 23;80(11):1702-1706. (PMID: 30282883)
Semin Immunopathol. 2012 Nov;34(6):793-813. (PMID: 22955326)
Clin Microbiol Rev. 2012 Apr;25(2):264-96. (PMID: 22491772)
Pathogens. 2023 Feb 08;12(2):. (PMID: 36839554)
Biol Reprod. 2015 Mar;92(3):82. (PMID: 25673564)
Front Microbiol. 2019 Feb 12;10:225. (PMID: 30809216)
Development. 2019 Nov 27;146(22):. (PMID: 31776138)
Rev Bras Ginecol Obstet. 2019 Sep;41(9):539-547. (PMID: 31546277)
J Biol Chem. 2013 May 3;288(18):12733-41. (PMID: 23443656)
Sci Rep. 2014 Mar 04;4:4259. (PMID: 24590372)
Tissue Cell. 2022 Oct;78:101907. (PMID: 36037656)
Front Microbiol. 2019 Apr 24;10:852. (PMID: 31068920)
PLoS One. 2012;7(12):e51384. (PMID: 23251513)
Exp Parasitol. 2023 Jul;250:108534. (PMID: 37100271)
Trop Biomed. 2019 Dec 1;36(4):898-925. (PMID: 33597463)
Microb Pathog. 2019 Oct;135:103618. (PMID: 31310832)
Curr Top Med Chem. 2002 Nov;2(11):1261-71. (PMID: 12171584)
Parasitol Res. 2001 Apr;87(4):269-74. (PMID: 11355674)
BJOG. 2014 Jan;121(1):22-33. (PMID: 23924273)
J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1:S30-5. (PMID: 25232475)
Microbes Infect. 2009 Apr;11(5):563-70. (PMID: 19344784)
Exp Parasitol. 2017 Feb;173:9-17. (PMID: 27939813)
Cell Host Microbe. 2009 Mar 19;5(3):259-72. (PMID: 19286135)
Front Cell Infect Microbiol. 2017 Aug 02;7:345. (PMID: 28824880)
Front Pediatr. 2022 Jun 16;10:894627. (PMID: 35783327)
فهرسة مساهمة: Keywords: P21 protein; Toxoplasma gondii; Trypanosoma cruzi; coinfection; congenital toxoplasmosis; maternal-fetal interface
المشرفين على المادة: 0 (Interleukin-8)
0 (Recombinant Proteins)
تواريخ الأحداث: Date Created: 20231102 Date Completed: 20231103 Latest Revision: 20231105
رمز التحديث: 20231106
مُعرف محوري في PubMed: PMC10617204
DOI: 10.3389/fimmu.2023.1243480
PMID: 37915581
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-3224
DOI:10.3389/fimmu.2023.1243480